Last month, Unilever announced it has signed an agreement to acquire the Health Food Drinks portfolio (GSK HFD) of GlaxoSmithKline (GSK) in India, Bangladesh and 20 other predominantly Asian markets. In 2018, the GSK HFD portfolio delivered total turnover of c.€550m, primarily through the Horlicks and Boost brands. Almost 90% of the turnover is in India. This deal highlight Unilever’s stated strategy of increasing its presence in health-food categories and in high-growth emerging markets. Viewing this news from packaging sector, we can expect growing demand for labels and packaging in these emerging markets as well.


Leave a Reply

Close Menu